Cyprus adds Mounjaro to its national health scheme for obesity and type 2 diabetes
Since 15 October, Cyprus's Gesy health system can reimburse Mounjaro for adults with a BMI of 40 or more, or 35 to 40 with heart disease or moderate-to-severe sleep apnoea, plus people with type 2 diabetes.
Since 15 October, Cyprus's Gesy health system can reimburse Mounjaro for adults with a BMI of 40 or more, or 35 to 40 with heart disease or moderate-to-severe sleep apnoea, plus people with type 2 diabetes. It needs a specialist prescription and prior approval, is dispensed through state hospital pharmacies at first, and can be funded for up to two years, while Ozempic stays first choice for type 2 diabetes.
Image credit: Cyprus Mail
Source: Cyprus Mail (19 Oct 2026).